GUGGENHEIM CAPITAL LLC CRNX — CRINETICS PHARMACEUTICALS IN

Ownership history in GUGGENHEIM CAPITAL LLC  ·  7 quarters on record

AI Ownership Summary

GUGGENHEIM CAPITAL LLC reported CRINETICS PHARMACEUTICALS IN (CRNX) in 7 quarterly 13F filings from 2024 Q1 through 2025 Q3. Peak portfolio weight reached 0.01% in 2024 Q4. The latest visible filing shows CRNX at 0.01% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CRNX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was GUGGENHEIM CAPITAL LLC's position in CRINETICS PHARMACEUTICALS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

CRNX was reported at 0.01% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CRNX stock page GUGGENHEIM CAPITAL LLC fund profile GUGGENHEIM CAPITAL LLC full holdings
How GUGGENHEIM CAPITAL LLC held CRNX — position size vs. price
% of Fund (quarterly)    CRNX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 ADDED — — — 30,239 +1,822 +6.4% 0.01% $1.3M 2025-11-13 $41.43
2025 Q2 REDUCED 7.9% +51.3% ❌ 28,417 -2,424 -7.9% 0.01% $817K 2025-08-13 $30.09
2025 Q1 ADDED — — — 30,841 +4,698 +18.0% 0.01% $1.0M 2025-05-14 $31.29
2024 Q4 REDUCED 7.2% -34.4% ✅ 26,143 -2,019 -7.2% 0.01% $1.3M 2025-02-13 $35.26
2024 Q3 REDUCED — — — 28,162 -287 -1.0% 0.01% $1.4M 2024-11-13 $58.92
2024 Q2 ADDED — — — 28,449 +24,031 +543.9% 0.01% $1.3M 2024-08-14 $51.43
2024 Q1 INITIATED — — — 4,418 — — 0.00% $207K 2024-05-14 $49.38

🏢 Other funds also holding CRNX

As of 2026 Q1 — sorted by position size

EcoR1 Capital, LLC 3Y 7Y 6.61% Novo Holdings A/S 3Y 7Y 4.56% First Light Asset Management, LLC 3Y 7Y 3.55% GordonMD Global Investments LP 3.21% Bellevue Group AG 3Y 7Y 2.84% Semanteon Capital Management, LP 2.71% ADAR1 Capital Management, LLC 2.44% Prosight Management, LP 3Y 7Y 2.08% Siren, L.L.C. 1.92% FARALLON CAPITAL MANAGEMENT LLC 3Y 7Y 1.73%

FAQ About GUGGENHEIM CAPITAL LLC and CRNX

These are the practical questions this page is built to answer before you even open the full history table.

How long has GUGGENHEIM CAPITAL LLC reported owning CRNX?

GUGGENHEIM CAPITAL LLC reported CRNX across 7 quarterly 13F filings, from 2024 Q1 through 2025 Q3.

What was the largest reported CRNX position in GUGGENHEIM CAPITAL LLC's portfolio?

The largest reported portfolio weight for CRNX was 0.01% in 2024 Q4.

What is the latest reported CRNX position on this page?

The most recent filing on this page is 2025 Q3, when GUGGENHEIM CAPITAL LLC reported 30,239 shares, equal to 0.01% of portfolio, with an estimated market value of $1.3M.

What does the chart on this CRNX ownership page compare?

The chart compares GUGGENHEIM CAPITAL LLC's quarterly CRNX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did GUGGENHEIM CAPITAL LLC time their CRNX position?

Based on 13F filing dates vs. subsequent CRNX price moves, GUGGENHEIM CAPITAL LLC correctly timed 4 out of 6 reported position changes (67%). The annualised alpha on CRNX relative to SPY over the holding period was -25.6%.

← Back to GUGGENHEIM CAPITAL LLC Holdings